kras mutation and glutathion glynac Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients? Oncometabolites in pancreatic cancer: Strategies
Oncometabolites in pancreatic cancer: Strategies and its implications PMC Supplementing Glycine and N Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial PMC Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines Metabolomics Springer Nature Link
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




